Proassurance CORP: management transactions · United States · SEC (Form 4)

About Proassurance CORP

ProAssurance Corp. (ticker PRA) is a U.S.-based specialty insurer listed on the NYSE in the United States, with a core franchise in professional liability lines. Headquartered in Birmingham, Alabama, the company operates as a property and casualty insurance holding company and positions itself around protecting professionals exposed to complex liability risks, especially in healthcare. Its current corporate structure dates to 2001, when Medical Assurance, Inc. and Professionals Group, Inc. merged, although management also emphasizes that the business has roots in the physician-led response to the medical liability crisis of the 1970s. ([s205.q4cdn.com](https://s205.q4cdn.com/588102317/files/doc_financials/2025/q4/PRA-2025-12-31-10K-FINAL.pdf)) ProAssurance’s operating model is anchored in medical professional liability insurance, written primarily through a group of subsidiaries including ProAssurance Indemnity Company, ProAssurance Casualty Company, Norcal Insurance Company, ProAssurance Insurance Corporation of America (PICA), and ProAssurance Specialty Insurance Company. The company also writes medical technology and life sciences products liability through Medmarc, legal professional liability through multiple subsidiaries, and workers’ compensation through Eastern Alliance Insurance Group. That mix gives PRA exposure to physicians, healthcare institutions, life sciences companies, and other professional service providers that require tailored risk solutions rather than commoditized commercial lines coverage. ([investor.proassurance.com](https://investor.proassurance.com/corporate-profile/default.aspx)) From a competitive standpoint, ProAssurance operates in a fragmented and cyclical property & casualty market where underwriting discipline, claims handling, financial strength, local relationships, and specialized expertise matter materially. The group highlights an A (Excellent) A.M. Best rating across several operating subsidiaries, which is an important differentiator in specialty insurance. In its 2025 reporting, ProAssurance said it generated approximately $0.9 billion of net premiums written, held $5.4 billion of total assets, and had $1.3 billion of shareholders’ equity, underscoring a meaningful balance-sheet base for a niche insurer. ([investor.proassurance.com](https://investor.proassurance.com/corporate-profile/default.aspx)) Geographically, the business is overwhelmingly U.S.-focused. ProAssurance’s executive offices are in Birmingham, Alabama, and it also lists an office in Okemos, Michigan. Its operations are therefore concentrated in the United States, across multiple state regulatory regimes, rather than being built around a broad international footprint. The stock trades on the NYSE under PRA, making it a familiar name for investors screening U.S. listed specialty insurers. ([s205.q4cdn.com](https://s205.q4cdn.com/588102317/files/doc_financials/2025/q4/PRA-2025-12-31-10K-FINAL.pdf)) Recent developments are dominated by the pending acquisition by The Doctors Company. In March 2025, the parties announced a definitive agreement under which The Doctors Company will acquire ProAssurance for $25.00 per share in cash. Shareholders approved the deal in June 2025, the HSR waiting period received early termination in July 2025, and as of February 23, 2026, multiple insurance regulatory approvals had been secured while other approvals remained pending. Management currently expects closing no later than June 30, 2026. For investors, the company is therefore in a late-stage transaction phase, which is likely to remain the key market narrative until closing. ([proassurancegroup.com](https://proassurancegroup.com/tdc))